MBOT - NASDAQ

Microbot Medical Inc.

MBOT·NASDAQ

$1.97

-0.51%

HealthcareMedical - Instruments & Supplies

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$89.77M

EPS-0.2900

P/E Ratio-6.79

Earnings Date08/11/2026

81.54M

Assets

1252%

3Y+755.0%

5Y+210.0%

10Y+2321.0%

3.99M

Total Liabilities

60%

3Y+77.0%

5Y+102.0%

10Y+139.0%

77.55M

Total Equity

2097%

3Y+964.0%

5Y+219.0%

10Y+4473.0%

Microbot Medical Inc. Funding & Solvency Profile

MBOT · NASDAQ

Current Assets

Cash & Cash Equivalents3.91M

Net Receivables241.00K

Inventory584.00K

Other Current Assets405.00K

Total Current Assets80 M

Non-Current Assets

Property, Plant & Equipment926.00K

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets796.00K

Total Non-Current Assets2 M

Total Assets

81.54M

Financial Health Analysis

Current Ratio

23.33x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.05x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

76 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

98% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Microbot Medical Inc. Balance Sheet

MBOT • NASDAQ

Microbot Medical Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	3.9M	3.1M	2.5M	2.5M	13.5M	19.7M	28.8M	5.2M	10.8M	2.7M	12.1M	25M	30.6M	8.5M	13.3M	19.7M	38.6M	30M	9.8M	51.8M
Short-Term Investments	74.7M	2.4M	3.9M	5.8M	2M	5M	2.5M	0.0	0.0	0.0	-11.7M	-397.0	0.0	13.9M	3.3M	190.8K	197K	4.2M	26.7M	4.1M
Cash & Short-Term Investments	78.6M	5.5M	6.4M	8.3M	15.5M	24.6M	31.3M	5.2M	10.8M	2.7M	437K	25M	30.6M	22.4M	16.6M	19.9M	38.8M	34.2M	36.5M	55.9M
Net Receivables	241K	300K	1.5M	103K	174K	0.0	101K	65K	35K	15K	29K	415.6K	595K	310.9K	268K	270K	766.1K	462.2K	529.3K	482.9K
Accounts Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.5K	108.8K	110.2K	54.5K	118.9K	87K	164.2K	264.6K	0.0
Other Receivables	241K	300K	1.5M	103K	174K	0.0	101K	65K	35K	15K	29K	256.2K	486.2K	200.8K	213.5K	151.1K	679K	164.2K	264.6K	482.9K
Inventory	584K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	984.4K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Prepaids	0.0	0.0	0.0	429K	126K	181K	185K	91K	81K	191K	25K	33.3K	530K	537.6K	506.5K	611K	560.1K	645.2K	1M	0.0
Other Current Assets	405K	49K	49K	3K	87K	424K	4.4M	437K	27K	400K	0.0	87K	130K	820.8K	22.1K	389K	0.0	0.0	0.0	1.1M
Total Current Assets	79.8M	5.8M	7.9M	8.8M	15.9M	25.3M	35.9M	5.8M	10.9M	3.3M	491K	26.5M	31.8M	24M	17.4M	21.2M	40.1M	35.3M	38.8M	57.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	926K	212K	406K	723K	888K	1M	1.2M	259K	90K	53K	38K	5.2M	5.3M	1.4M	2.1M	2.6M	2.9M	3.2M	3.9M	3.6M
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	184.0	0.0	2.1M	2M	1.9M	1.9M	2M	0.0	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.8K	356.9K	1.8M	1.8M	2M	3M	3.6M	645.5K	762.7K	876.2K
Goodwill & Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46K	356.9K	4M	3.8M	3.9M	4.9M	5.7M	645.5K	762.7K	876.2K
Other Non-Current Assets	796K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-46K	375.1K	437.3K	947.3K	1.9M	1.9M	2.5M	2.1M	4.9M	4.9M
Total Non-Current Assets	1.7M	212K	406K	723K	888K	1M	1.2M	259K	90K	53K	38K	5.9M	9.7M	6.1M	7.8M	9.4M	11M	5.9M	9.5M	9.3M
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-241.0	-281.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	81.5M	6M	8.3M	9.5M	16.8M	26.3M	37.1M	6.1M	11M	3.4M	529K	32.4M	41.6M	30.2M	25.2M	30.6M	51.2M	41.2M	48.3M	66.9M
LIABILITIES
CURRENT LIABILITIES
Total Payables	511K	165K	357K	116K	279K	275K	284K	630K	78K	512K	25K	1.8M	1.2M	999.4K	1.1M	1.1M	890.6K	1.1M	1.8M	620.8K
Accounts Payable	511K	165K	357K	116K	279K	275K	284K	630K	78K	201K	25K	1.8M	1.2M	216.9K	206.9K	1.1M	890.6K	1.1M	1.8M	620.8K
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	622K	0.0	0.0	0.0	782.5K	859.6K	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	811K	2.4M	1.4M	1.4M	883K	664K	755K	64K	271K	18K	78.4K	77.7K	1.6M	1.4M	2.2M	2.1M	1.5M	1.9M	3.1M
Short Term Debt	296K	0.0	0.0	283K	0.0	0.0	0.0	0.0	0.0	0.0	1.4M	6.8M	4.9M	206.3K	191.3K	176.3K	161.3K	167.9K	153.8K	205.8K
Capital Lease Obligations (Current)	0.0	70K	191K	0.0	278K	187K	143K	0.0	0.0	0.0	20K	20.2K	21.3K	6.9K	18K	67.8K	68K	0.0	-43.9K	-1.6M
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8K	16.8K	67.2K	74.4K	43.9K	45.9K	119.5K	43.9K	43.9K	16.8K
Other Current Liabilities	2.6M	1.4M	804K	298K	0.0	0.0	3.7M	3.4M	386K	0.0	-2.6M	9.6M	7.8M	2.2M	3M	4M	3.2M	2.5M	2M	159.8K
Total Current Liabilities	3.4M	2.5M	3.8M	2.1M	2M	1.3M	4.8M	4.8M	528K	783K	174K	11.5M	9.1M	5.1M	5.7M	5.5M	6.5M	5.3M	5.8M	4.1M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76K	419K	10.3M	9.2M	125K	331.3K	522.5K	698.8K	860K	1M	1.1M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.3K	0.0	0.0	79.7K	96.6K	113.4K	130.2K	147K	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.8K	1.4M	0.0	1.2K	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	528K	813K	-45.1K	4.7M	8.1M	10.9M	8.4M	8.9M	13.3M	13.1M	6.2M	7.2M
Total Non-Current Liabilities	569K	41K	40K	179K	402K	626K	760K	0.0	528K	889K	419K	15.1M	17.5M	11.1M	8.8M	9.6M	14.2M	14.1M	7.2M	8.3M
Capital Lease Obligations	569K	111K	231K	179K	680K	813K	903K	0.0	0.0	0.0	35.9K	29.4K	50.7K	19.5K	18K	85.8K	153.8K	25.3M	25.3K	0.0
Total Liabilities	4M	2.5M	3.8M	2.2M	2.4M	2M	5.6M	4.8M	1.1M	1.7M	593K	26.6M	26.6M	16.2M	14.5M	15.1M	20.7M	19.4M	13.1M	12.5M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	0.0	-3.4M	-3.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Common Stock	672K	195K	118K	80K	72K	72K	72K	31K	27K	266K	132K	687.3K	551.4K	375.1K	1.5M	1.3M	1.2M	949.5K	806.8K	780.5K
Additional Paid-In Capital	181M	94.3M	83.9M	76M	69.9M	68.5M	70M	32.5M	30.6M	14.5M	3.1M	425.4M	401.7M	374.5M	341.8M	325.4M	314.9M	279.9M	264.6M	255.3M
Retained Earnings	-104.1M	-90.9M	-79.5M	-68.8M	-55.6M	-44.3M	-35.1M	-27.9M	-20.6M	-13M	-3.4M	-420.3M	-387.5M	-361.1M	-332.6M	-311.3M	-286M	-259M	-229.9M	-204.9M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4K	65.4K	252.1K	193.2K	40.7K	119.7K	394.7K	-7.7K	-283.9K	3.2M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-47.4K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	77.6M	3.5M	4.5M	7.3M	14.4M	24.3M	31.5M	1.3M	10M	1.7M	-64K	5.9M	15M	14M	10.7M	15.5M	30.5M	21.8M	35.2M	54.4M
Total Equity	77.6M	3.5M	4.5M	7.3M	14.4M	24.3M	31.5M	1.3M	10M	1.7M	-64K	5.9M	15M	14M	10.7M	15.5M	30.5M	21.8M	35.2M	54.4M
SUMMARY
Total Liabilities & Equity	81.5M	6M	8.3M	9.5M	16.8M	26.3M	37.1M	6.1M	11M	3.4M	529K	32.4M	41.6M	30.2M	25.2M	30.6M	51.2M	41.2M	48.3M	66.9M
Total Investments	74.7M	2.4M	3.9M	5.8M	2M	5M	2.5M	0.0	0.0	0.0	-11.7M	-24.2M	-30.2M	13.9M	3.3M	190.8K	197K	4.2M	26.7M	4.1M
Total Debt	865K	111K	231K	462K	680K	813K	903K	0.0	0.0	76K	10.3M	15M	13.1M	350.8K	540.5K	784.6K	1M	1M	1.2M	1.4M
Net Debt	-3M	-3M	-2.2M	-2.1M	-12.8M	-18.8M	-27.9M	-5.2M	-10.8M	-2.6M	-1.8M	-10M	-17.5M	-8.1M	-12.8M	-18.9M	-37.6M	-29M	-8.6M	-50.4M
Shares Outstanding	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432	45,570,432

SEC Filings

MBOT - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 02, 2026	June 02, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 26, 2026	May 26, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 15, 2026	May 15, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 14, 2026	May 14, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 13, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 22, 2026	April 22, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 14, 2026	April 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 13, 2026	April 13, 2026	2026	View Filing

Showing 1 to 10 of 680 filings

Related Guides

Blog Categories

Continue your MBOT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.